These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7349817)

  • 1. Cystic disease, family history of breast cancer, and use of oral contraceptives.
    Vakil DV; Elinson L; Morgan RW
    Cancer Detect Prev; 1981; 4(1-4):511-5. PubMed ID: 7349817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Contraception without risk of breast disease: epidemiologic and physiopathologic arguments].
    Le Coutour X
    NPN Med; 1985 Apr; 5(88):471-6. PubMed ID: 12315304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral contraceptive use and risk of breast cancer among women with a family history of breast cancer: a prospective cohort study.
    Silvera SA; Miller AB; Rohan TE
    Cancer Causes Control; 2005 Nov; 16(9):1059-63. PubMed ID: 16184471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Researchers can now investigate long-term effects of OCs on cancer.
    Rubin GL; Peterson HB
    Contracept Technol Update; 1985 Jan; 6(1):7-12. PubMed ID: 12279918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrocystic breast disease in oral-contraceptive users. A histopathological evaluation of epithelial atypia.
    LiVolsi VA; Stadel BV; Kelsey JL; Holford TR; White C
    N Engl J Med; 1978 Aug; 299(8):381-5. PubMed ID: 566853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of benign and malignant breast disorders in women taking hormones (contraceptive pill or hormonal replacement therapy).
    Tzingounis V; Cardamakis E; Ginopoulos P; Argiropoulos G
    Anticancer Res; 1996; 16(6C):3997-4000. PubMed ID: 9042326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risks of oral contraceptive use in women over 35.
    Stenchever MA
    J Reprod Med; 1993 Dec; 38(12 Suppl):1030-5. PubMed ID: 8120860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral contraceptive use and BRCA penetrance: a case-only study.
    Pasanisi P; Hédelin G; Berrino J; Chang-Claude J; Hermann S; Steel M; Haites N; Hart J; Peled R; Gafà L; Leggio L; Traina A; Amodio R; Primic-Zakelj M; Zadnik V; Veidebaum T; Tekkel M; Berrino F
    Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2107-13. PubMed ID: 19549808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral contraceptives and reduced risk of benign breast diseases.
    Ory H; Cole P; MacMahon B; Hoover R
    N Engl J Med; 1976 Feb; 294(8):419-22. PubMed ID: 1246309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of teenage oral contraceptive use in a population-based series of early-onset breast cancer cases who have undergone BRCA mutation testing.
    Jernström H; Loman N; Johannsson OT; Borg A; Olsson H
    Eur J Cancer; 2005 Oct; 41(15):2312-20. PubMed ID: 16118051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Possible link between long-term oral contraceptive use and cervical cancer].
    Perspect Int Planif Fam; 1987; (Spec No):40-1. PubMed ID: 12269054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Oral contraceptives and risk of benign tumors of the breast: recent data from the literature].
    Simard A
    Union Med Can; 1977 Aug; 106(8):1115-9. PubMed ID: 333686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral contraceptive use and fibrocystic breast disease with special reference to its histopathology.
    Pastides H; Kelsey JL; LiVolsi VA; Holford TR; Fischer DB; Goldenberg IS
    J Natl Cancer Inst; 1983 Jul; 71(1):5-9. PubMed ID: 6575209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Breast cancer and heredity: results of a population case-control study in Girona].
    de Sanjosé S; Viladiu P; Cordón F; Vilardell L; Marcos R; Izquìerdo A
    Med Clin (Barc); 1998 Mar; 110(10):370-2. PubMed ID: 9567278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Oral contraception and its beneficial gynecological effects].
    Belaisch J; Hommais-loufrani B
    Fertil Contracept Sex; 1988 Mar; 16(3 Suppl):3-7. PubMed ID: 12282188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benign breast disease: estriol proportions and family history of breast cancer.
    Vakil DV; Morgan RW; Elinson L
    Cancer Detect Prev; 1981; 4(1-4):517-23. PubMed ID: 7349818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral contraceptive use and other risk factors in relation to HER-2/neu overexpression in breast cancer among young women.
    Gammon MD; Hibshoosh H; Terry MB; Bose S; Schoenberg JB; Brinton LA; Bernstein JL; Thompson WD
    Cancer Epidemiol Biomarkers Prev; 1999 May; 8(5):413-9. PubMed ID: 10350436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral contraceptive use and the risk of breast cancer in women with a "prior" history of benign breast disease.
    Stadel BV; Schlesselman JJ
    Am J Epidemiol; 1986 Mar; 123(3):373-82. PubMed ID: 3946384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Oral contraceptive use and the risk of cancer].
    Wingo PA
    Fertil Contracept Sex; 1989 Feb; 17(2):125-32. PubMed ID: 12281877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.